Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Budget Impact of the Oncotype DX Breast Recurrence Score® Test in Patients with Early Primary Hormone-Receptor-Positive, HER2-Negative, Node-Positive Breast Cancer in Germany.
Breast Care (Basel). 2024 Feb;19(1):27-33. doi: 10.1159/000534096. Epub 2023 Dec 5.
Breast Care (Basel). 2024.
PMID: 38384494
Budget impact of the Oncotype DX® test compared to other gene expression tests in patients with early breast cancer in Germany.
Lux MP, Minartz C, Müller-Huesmann H, Sandor MF, Herrmann KH, Radeck-Knorre S, Neubauer AS.
Lux MP, et al. Among authors: radeck knorre s.
Cancer Treat Res Commun. 2022;31:100519. doi: 10.1016/j.ctarc.2022.100519. Epub 2022 Jan 20.
Cancer Treat Res Commun. 2022.
PMID: 35093682
Free article.
Item in Clipboard
Cite
Cite